6 important truths about COVID-19 vaccines

With the vaccines now being administered at sites around the US, it is important to address misinformation surrounding the effort.

Kanneboyina Nagaraju, Professor of Pharmacy and Pharmaceutical Sciences, Binghamton University, State University of New York • conversation
Feb. 18, 2021 ~10 min

Will the COVID-19 vaccine work as well in patients with obesity?

Americans with excess weight and obesity have been hit hard by COVID-19. Now there is reason to believe they may not get the same protection from the vaccines.

Cate Varney, Clinical Physician, University of Virginia • conversation
Feb. 8, 2021 ~7 min

What a squeezed rubber ducky suggests about the lingering effects of vaccine misinformation

Vaccine hesitancy will not go away fast. In fact, there are parallels in the physical world to how quickly or slowly an object returns to its normal state.

Feng Fu, Assistant Professor of Mathematics, Dartmouth College • conversation
Feb. 4, 2021 ~8 min

Why it takes 2 shots to make mRNA vaccines do their antibody-creating best – and what the data shows on delaying the booster dose

With slow vaccine distribution and manufacturing, some people won't get the second dose on time. But does it matter?

William Petri, Professor of Medicine, University of Virginia • conversation
Jan. 28, 2021 ~6 min

Your corner pharmacy – joining the front lines of the COVID-19 fight

Two pharmacists involved in COVID-19 vaccine preparation explain the role pharmacists are poised to play in expanding vaccine access.

Danielle Mayer, Assistant Professor, Department of Pharmacy Practice, Jefferson College of Pharmacy, Thomas Jefferson University • conversation
Jan. 25, 2021 ~7 min

Americans have unrealistic expectations for a COVID-19 vaccine

Two in five Americans say they don't want a COVID-19 vaccine, which is a problem. Finding out what Americans do want from a vaccine might help.

Matt Motta, Assistant Professor of Political Science, Oklahoma State University • conversation
Jan. 13, 2021 ~9 min

Vaccine delays reveal unexpected weak link in supply chains: A shortage of workers

The shipment of goods to suppliers has become technologically sophisticated. Delays in getting out the COVID-19 vaccine to people show that the breakdowns come down to something more basic.

Anna Nagurney, John F. Smith Memorial Professor of Operations Management, University of Massachusetts Amherst • conversation
Jan. 8, 2021 ~10 min

How many people need to get a COVID-19 vaccine in order to stop the coronavirus?

Researchers say around 70% of the US needs to get the coronavirus vaccine to stop the pandemic. But questions around the vaccines and regional differences add some uncertainty to that estimate.

Pedro Mendes, Professor of Cell Biology, University of Connecticut • conversation
Jan. 5, 2021 ~8 min

The cold supply chain can't reach everywhere – that's a big problem for equitable COVID-19 vaccination

So far, the only COVID-19 vaccines authorized for use need to be kept frozen. But there are many places in the world that can't support a cold supply chain.

Charles M. Schweik, Professor of Environmental Conservation, University of Massachusetts Amherst • conversation
Jan. 4, 2021 ~7 min

Why it matters that the coronavirus is changing – and what this means for vaccine effectiveness

A new strain of the SARS-CoV-2 virus that causes COVID-19 appears to be spreading fast in the the UK. What does this mean for vaccine developers and vaccinations?

David Kennedy, Assistant Professor of Biology, Penn State • conversation
Dec. 22, 2020 ~6 min

/

3